StockData
Septerna, Inc. logo

Septerna, Inc. (SEPN) stock

SEPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30176% above fair value
$41.67−0.93 (-2.18%)

Close on Nov 16, 2026Market cap $1.95BP/E –Yield –

Septerna cash

Cash and short-term investments held at the end of each period.

Septerna's cash was $478.60M at Sep 30, 2026. For fiscal 2025 it was $391.09M, up 11.4% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$391.09M+11.4%
FY2024Dec 31, 2024$350.92M+296.6%
FY2023Dec 31, 2023$88.48M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$478.60M+0.9%
Q2 FY2026Jun 30, 2026$372.32M+14.0%
Q1 FY2026Mar 31, 2026$347.40M+3.4%
Q4 FY2025Dec 31, 2025$391.09M+11.4%
Q3 FY2025Sep 30, 2025$474.35M+263.4%
Q2 FY2025Jun 30, 2025$326.56M+149.0%
Q1 FY2025Mar 31, 2025$336.01M+313.1%
Q4 FY2024Dec 31, 2024$350.92M+296.6%
Q3 FY2024Sep 30, 2024$130.53M+32.5%
Q2 FY2024Jun 30, 2024$131.17M–
Q1 FY2024Mar 31, 2024$81.34M–
Q4 FY2023Dec 31, 2023$88.48M–
Q3 FY2023Sep 30, 2023$98.52M–

More Septerna figures

See a number that looks wrong?